|
LMNB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.178200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.551400E-01 |
| Normal-vs-Stage2 |
2.936800E-01 |
| Normal-vs-Stage3 |
6.981800E-01 |
| Normal-vs-Stage4 |
6.443600E-01 |
| Stage1-vs-Stage2 |
1.597520E-04 |
| Stage1-vs-Stage3 |
6.990800E-01 |
| Stage1-vs-Stage4 |
9.092200E-01 |
| Stage2-vs-Stage3 |
6.618700E-03 |
| Stage2-vs-Stage4 |
1.947800E-02 |
| Stage3-vs-Stage4 |
8.761000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.016000E-01 |
| Normal-vs-AfricanAmerican |
9.812600E-01 |
| Normal-vs-Asian |
6.592200E-01 |
| Caucasian-vs-AfricanAmerican |
4.186400E-01 |
| Caucasian-vs-Asian |
7.189800E-01 |
| AfricanAmerican-vs-Asian |
5.475000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.080600E-01 |
| Normal-vs-Female |
7.692000E-01 |
| Male-vs-Female |
5.530400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.618400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.994200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.816800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.072620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.206700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.521820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.544000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.849000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.206160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.691410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.829200E-01 |
| Classical-VS-Follicular |
8.24870000082356E-08 |
| Classical-VS-Other |
4.971600E-01 |
| Classical-VS-Normal |
3.997000E-01 |
| Tall-VS-Follicular |
2.237100E-04 |
| Tall-VS-Other |
3.499200E-01 |
| Tall-VS-Normal |
2.654600E-01 |
| Follicular-VS-Other |
2.914000E-01 |
| Follicular-VS-Normal |
1.740360E-01 |
| Other-VS-Normal |
9.341600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.496200E-01 |
| Normal-vs-N1 |
9.293400E-01 |
| N0-vs-N1 |
9.571200E-01 |
|
|
